Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 1st Quarter - Termination (No Activity)

SYNGAP1 FOUNDATION

via BUCHANAN INGERSOLL & ROONEY PC

1st Quarter (Jan 1 - Mar 31) · 2025Posted Apr 21, 2025Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: SYNGAP1 FOUNDATION
Description: Nonprofit patient advocacy and research organization
Location: District of Columbia · United States of America

Registrant

Firm: BUCHANAN INGERSOLL & ROONEY PC
Description: law firm
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

SYNGAP1 FOUNDATION — Lobbying — Receipts Report